US Drug Delivery Systems Market to grow 9% - Hitting $135 billion by 2015

Report this content

Piribo, the online destination for Pharma intelligence, has added a new report.

According to the report “Market for Drug Delivery Systems in the US” available at drug delivery systems market in theUS is visualised to grow and to over $135 billion by 2015, as a result of growth of almost 9% annually since 2010. The largest share is expected to come from oral drugs. Parenteral or injectable drug delivery systems are to grow at a rapid speed as well, especially in cancer applications.

The fastest growth in the coming years is likely to be witnessed by implantable drug delivery systems. This segment is going to be upgraded with the latest range drugeluting stents with more sophisticated designs and reduced risks. Also to have an astounding growth will be the drug delivery systems for hormones and cardiology agents. Product development lays emphasis on introducing innovative technologies which help improve dosing and monitor patient safety real well. It includes services such as multiple dosing arrangement in a single tablet, progressive meters etc.

Rapid growth of demand for drug delivery systems is thanks to advanced technology innovation and also generic contention. It has also prompted pharmaceutical corporations to accommodate widely prescribed medicines to expand their commercial exclusivity span beyond patent expiry dates of genuine ingredients. With ever improving mechanisation, possibilities of massive breakthroughs in this field look increasingly likely.

View the report “Market for Drug Delivery Systems in the US” 

press@reportbuyer.com

t. 44 (0) 20 7060 7474

Pharmaceutical-market-research.com is the source for information products concerning the global biotechnology, healthcare, medical device and pharmaceutical industries. With over 26,000 market reports available, executives can find a current and comprehensive range of specialised intelligence. www.pharmaceutical-market-research.com is a service from Piribo Ltd, which was founded in 2004.